Loading
Latest filing published 22 May 2025 for Helix BioPharma Corp..
No signal scores available.
All filings by Laevoroc Medical AG CH on record concern Helix BioPharma Corp. We count 2 filings, every one of them for a trade on 16 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 22 May 2025, reports a transaction in Helix BioPharma Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations